2019 MTRC Market Access Retainer - order now and save 20% of the budget

Nov 2018

MTRC, a leading European Med Tech market access consultancy is offering an opportunity to access 2019 market access retainer scheme using the discounted price during November-December 2018.

The benefit to your organization of entering into this scheme is the forward planning of market access-related project activities and more effective budget management.

The MTRC market access retainer scheme offers a number of services and inclusion into this scheme would guarantee your organization access to a pre-defined amount of the following services:

Reimbursement analysis and strategy projects
Access to ready-made MTRC reimbursement reports
Evidence generation strategy projects
Access to procedure volume information
Overviews of EU reimbursement in slide deck format
Bespoke training for your organization and affiliates in EU market access

Our current services cover 18 countries including: Austria, Belgium, Czech Republic, Denmark, England, Finland, France, Germany, Hungary, Italy, The Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden and Switzerland.

The latest related news

MTRC HTA and Reimbursement Alerts service – a new industry standard in accessing market access information

Nov 2021

In August, MTRC launched two subscription services with a focus on all published, initiated or ongoing HTA and reimbursement reports and decisions for medical devices, procedures and IVD tests. HTA Alerts is a global service and covers 56 organizations from 24 countries. Reimbursement Alerts is focused on 14 key European countries. All alerts are tailed to the technologies of interest for each client. You can request a free-of-charge 2-month sample of reporting for both services

MTRC is now an ISO 9001:2015 certified organization

Sep 2021

In September 2021, MTRC received a certificate of conformity of the internal processes with the ISO 9001:2015 (quality management systems) standard. The certificate was issued by the United Kingdom Accreditation Service, UKAS. This confirms the commitment of the MTRC team to the provision of high-quality reimbursement services in Europe.

MTRC released a 2021 update of its syndicated report on innovation funding schemes in Europe

Aug 2021

A syndicated report (135 pages) reviews details of innovation funding and coverage with evidence development schemes in Europe, including Austria, Belgium, England, France, Germany, the Netherlands, and Switzerland. For each scheme, information about objective, inclusion criteria, applicant, stakeholders involved, clinical and economic evidence requirements, and statistics (including at least 2019-2020 data; but for most schemes – statistics for multiple years) is included.

MTRC released update of the syndicated report on reimbursement decisions for IVD tests in 5 EU countries (now covering 3-year period of 2018-2020)

Jul 2021

MTRC released an update of the syndicated report on reimbursement decisions for IVD tests in 5 EU countries (Belgium, France, Germany, the Netherlands, and Switzerland). The updated report covers 3-year period of 2018-2020. Broader coverage gives a better understanding of the activity of the reimbursement organizations.

MTRC HTA and Reimbursement Alerts service – a new industry standard in accessing market access information

May 2021